Viatris Inc. (VTRS)

Viatris Inc. is a global healthcare company established in November 2020 through the merger of Mylan N.V. and Upjohn, a division of Pfizer. Headquartered in Canonsburg, Pennsylvania, Viatris focuses on empowering people worldwide to live healthier at every stage of life. The company provides a broad portfolio of medications, including branded, generic, and over-the-counter products across a variety of therapeutic areas. Viatris is led by CEO Scott A. Smith, who brings extensive leadership experience in the pharmaceutical industry. In 2022, Viatris reported revenue of approximately $16.26 billion, showcasing its significant impact in the healthcare sector. With a mission of providing affordable and accessible medicines, Viatris operates in over 165 countries and territories, aiming to bridge the gap in global healthcare needs by enhancing access and sustainable operations.